Plain-English translation of NCT06081348 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This research study is testing whether —a medication already used to treat anxiety in many children—might also work well for children and teens with developmental disorders like autism and ADHD who experience significant anxiety. Right now, there are no medications officially approved specifically for anxiety in children with these conditions, even though anxiety is very common in this group. This pilot study will help researchers understand if could be helpful and which anxiety measures work best for future, larger studies.
Children and teens with autism, ADHD, and other developmental disorders often struggle with severe anxiety, but doctors don't have approved medications designed specifically for them. This medication has a strong track record helping children with anxiety in general, but it hasn't been properly studied in children with developmental disorders, so we need to know if it works for this group.
You likely qualify if…
You likely don't qualify if…
If you join this study, you will be randomly assigned to take either the medication or a placebo (a pill with no active ingredient) every day for a set period of time. You will have regular visits with the research team where they will check on your anxiety symptoms, any side effects, and how you're doing overall. The study includes questionnaires and interviews to measure how your anxiety has changed, and researchers will keep a close eye on your safety throughout.
AI-generated summary from trial data · Aug 6, 2026 · Not medical advice
Canada